Vascular inflammation as a therapeutic target for prevention of cardiovascular disease.

被引:8
作者
Clark L.T. [1 ]
机构
[1] Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Box 1199, Brooklyn, 11203, NY
关键词
Ramipril; Gemfibrozil; Vascular Inflammation; Secondary Prevention Trial; Ciprofibrate;
D O I
10.1007/s11883-002-0027-1
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:77 / 81
页数:4
相关论文
共 115 条
[1]  
Ross R(1999)Atherosclerosis—an inflammatory disease N Engl J Med 340 115-126
[2]  
Kaplan RC(2001)Systemic inflammation as a cardiovascular disease risk factor and as a potential target for drug therapy Heart Disease 3 326-332
[3]  
Frishman WH(1997)Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 973-979
[4]  
Ridker PM(1998)Prospective studies of C-reactive protein as a risk factor for cardiovascular disease J Invest Med 46 392-395
[5]  
Cushman M(2001)Effects of low-dose aspirin on serum C-reactive protein and thromboxand B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay J Am Coll Cardiol 37 2036-2041
[6]  
Stampfer MJ(1999)Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin Circulation 100 793-798
[7]  
Ridker P(1999)Long-term effects of pravastatin on plasma concentration of C-reactive protein Circulation 100 230-235
[8]  
Haughey P(2001)Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 1959-1965
[9]  
Feldman M(2001)Effect of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels Circulation 103 1933-1935
[10]  
Jialal I(1998)Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization Circulation 97 2433-2444